Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.

Slides:



Advertisements
Similar presentations
Planning M&E to Tell Our ACSM Story. Objectives Discuss how ACSM activities can address barriers to help reach national TB control targets. Describe how.
Advertisements

Module 7: Patient Education. Learning Objectives Explain the importance of patient education during the TB treatment process Describe the District TB.
Module 11: Community TB Care Image source: Pierre Virot, World Lung Foundation.
Improving diagnosis TB laboratory strengthening.
Using the Supervisory Checklist Module 9 Part B. How do I monitor? The supervisory checklist gives you a structure you can use … … but it should not limit.
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
ORGANIZATION. 2 Problem scenario  Develop an organizational chart for your laboratory showing lines of authority from the head of the organization to.
World Health Organization TB Case Definitions
Module 9 Part A: Monitoring and Evaluation *Image courtesy of: World Lung Foundation.
Dr Samah Kotb Lecturer of Biochemistry 1 CLS 432 Dr. Samah Kotb Nasr El-deen Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Nasr.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Indicators, Data Sources, and Data Quality for TB M&E
1 Assessment: Audits. Assessment: Audits - Module 9 2 Learning Objectives At the end of this activity, you will be able to: Develop a process to prepare.
Laboratory Management - 1
1 Module PLANNING AND ORGANIZING EXTERNAL QUALITY ASSESSMENT.
Diagnosis of TB.
Unit 4: Monitoring Data Quality For HIV Case Surveillance Systems #6-0-1.
1 HIV Drug Resistance Training Module 9: A Systems Approach to Laboratory Quality.
4 th National Anti-tuberculosis Drug Resistance Survey Botswana, 2007.
1 Interpretation and use. 2 The walls inside are plastered with laboriously made graphs…
Module 4: From Suspect to Confirmed Case. Learning Objectives Explain why sputum microscopy is important Describe the process for confirming a TB suspect.
Unit 6: Training and Supervision # Warm Up Questions: Instructions  Take five minutes now to try the Unit 6 warm up questions in your manual. 
Implementing Quality Improvement Introduction to PDSA cycles.
1 Accreditation and Certification: Definition  Certification: Procedures by which a third party gives written assurance that a product, process or service.
Module 5: Assuring the Quality of HIV Rapid Testing
1 Module PROBLEM-ORIENTED SUPERVISION AND PROBLEM SOLVING.
1 Module ON-SITE SUPERVISION OVERVIEW. 2 Content Overview What is on-site supervision? Advantages and disadvantages of on-site supervision Organization.
Monitoring and Evaluation Module 12 – March 2010.
1 Module OVERVIEW OF EXTERNAL QUALITY ASSESSMENT.
Unit 10. Monitoring and evaluation
Adolescent HIV Care and Treatment Module 14: Monitoring, Evaluation, and Quality Improvement 1.
Introduction to the course 1. Agenda Include: TECHNICAL ISSUES PRACTICAL ISSUES 2.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Monitoring, supervision and quality control IDSP training module for state and district surveillance officers Module 11.
Elements of the Cohort Review Approach Harvey L. Marx, Jr. Lisa Schutzenhofer TB Program Controller TB Program Manager.
P1 External Quality Assessment (EQA) Proficiency Testing.
Indicators for ACSM.
Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Evaluation Plan New Jobs “How to Get New Jobs? Innovative Guidance and Counselling 2 nd Meeting Liverpool | 3 – 4 February L Research Institute Roula.
High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
1 ON-SITE SUPERVISION – CHECKLISTS. 2 Checklists Serve as documentation of the visit and record of current conditions and actions needed Help carrying.
Module 8: Recording and reporting Global Laboratory Initiative – Xpert MTB/RIF Training Package.
Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015 Introduction to Quality Control.
Facilitate Group Learning
Public Health Laboratory Department of Public Health Ministry of Health National Early Warning Alert Response Surveillance (NEWARS) Sonam.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
Role of Laboratory Services in TB Control Dr Mohammad Rahbar Professor of Microbiology Department Microbiology Reference health Laboratory,Tehran iran.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
1 Module PANEL TESTING Intermediate level. 2 Content Overview What is panel testing? What is panel testing used for? Organization of a panel testing round.
Module 9 Recording and reporting culture results Exercise 1.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Program Performance Criteria.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Introduction to Quality Assurance. Quality assurance vs. Quality control.
TB- HIV Collaborative activities in Romania- may 2006 status
11 ii. Develop a plan for aDSM
HOME VISIT.
This is an archived document.
Presentation 10 Analysing results and defining cases
Find and Treat All Missing Persons with TB
Shaimah Al-Failakawi Al Amiri Hospital Laboratory Quality Manager
Module 9 Recording and reporting culture results
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
11 iii. Define management and supervision roles and responsibilities
Indicators, Data Sources and Data Quality for TB M&E
Presentation transcript:

Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation

Describe how to monitor lab services - Proper reporting and recording How to analyze data for - quality - effectiveness Learning Objectives

Monitoring Laboratory Services

How do I work in the laboratory? 1.Communication between the laboratory and the clinic is the most important issue to look at 2.You can also collect some basic indicators on overall lab performance

What you probably can’t do 1.You won’t be able to assess the quality of smears / microscopy 2.Lab experts need to advise on safety protocols and correct use of equipment

These are the tools at your disposal TalkObserveAnalyse AttitudesActionsConsistency UnderstandingProcessesAccuracy MoraleConditionsEffectiveness

 Measure key indicators related to quality of diagnosis  Accurate  Verifiable  Timely  Identify problems in implementing TB control activities (e.g., laboratory reporting delays)  Improve lab / program linkages and accountability  Influence laboratory practice Benefit for BNTP

 Sputum Dispatch Register  Facility TB Register  Lab Register Cross-Checking for Quality

Key Elements for Quality Quality begins with DATA –Proper registration of Suspects Specimens Results –Three Key Tools Suspect and Sputum Dispatch Register (SSD) Laboratory Register TB Facility Register (for confirmed cases)

Lab Procedure for TB Microscopy 1. Patient details recorded (specimen container and request form) 2. Forms and container assigned lab reference number 3. Details entered in Laboratory Register. 4. Specimen quality checked and recorded 5. Smear prepared. 6. Specimen stained, examined 7. Results reported back to facility.

Proper Registration is a 6-Part Process SSD Register 1.Suspects are registered 2.Specimens sent to Lab Lab Register 3. Suspects are confirmed as cases or not 4. Results sent back to clinic SSD Register 5. Lab results are recorded in SSD for each suspect TB Register 6. Confirmed CASES are registered in Facility TB Register

Register Cross-checks What is cross-checking? Why is it important? Who should do it? How is it done?

What are Cross-checks? Cross-checking is a simple task used to reveal many basic workflow and communications problems between the program and the laboratory. It should be done regularly, and in conjunction with laboratory staff.

Cross-checking involves the SSD Register/ TB Register and the Lab Register SSD Register Lab Register Facility Register

Pt One Specimen Pt Two Specimen Pt Three Specimen 1.Check the lab register to see that all suspects from the SSD and their respective specimens are recorded. SSD Register Lab Register 1. Patient One 2. Patient Two 3. Patient Three

1. Sputum Smear Positive 2. Sputum Smear Negative 3. Sputum Smear Positive 2. Check the SSD to be sure there are recorded results for every suspect SSD Register Lab Register Pt 1. Sputum Smear Positive Pt 2. Sputum Smear Negative Pt 3. Sputum Smear Positive

3. Next compare the SSD with the TB Register. Be sure that each confirmed smear-positive case is registered and has their smear-results recorded in the Facility Register. TB Register SSD Register 1. Sputum Smear Positive Pt 2. Ruled out- Not Registered 3. Sputum Smear Positive 1. Sputum Smear Positive 2. Sputum Smear Negative 3. Sputum Smear Positive

Sputum Smear Positive If you find a case in the Lab register which is NOT in the SSD register, then a case has been missed. SSD Register Lab Register Sputum Smear Positive Negative Sputum Smear Positive ??

Sputum Smear Positive Similarly, if you find a sputum smear-positive case in the Lab register and SSD which is NOT in the Facility Register, then a case has been missed. TB Register Lab Register Sputum Smear Positive Negative Sputum Smear Positive ?? In these situations the case needs to be entered and treatment commenced ASAP.

Pt. 1 Sputum SS+ SSD Register Lab Register Patient 1 Patient 2 Patient 3 ?? Conversely, if there are no data for a Suspect in the Lab Register, this means the specimens were not received or processed. Time to investigate!! ?? In these situations, new specimens need to be submitted and inquiries made regarding specimen transport and receiving procedures.

Exercises  Divide into pairs. Using the handout conduct a lab and patient register cross- check DISCUSSION  What problems did you find?  What are the underlying issues?  How would you deal with them?

Communicating about Lab Issues  The Laboratory Manager  The District Coordinator

The Lab and the District Coordinator  Talking to the laboratory manager can be interesting.  Listen carefully and identify issues for follow- up.  A good tip: Make sure that you speak with the Lab Manager and Clinic Matrons separately, at least once per M&E Visit – even if it is just an informal conversation. 

Key Questions to Report on  Are there recording and reporting issues?  Are TB patients being lost?  Are AFB results received from the lab within 24 hours of specimen collection?  Are all TB smear and culture results reported by laboratories?  Is the lab receiving a good quality specimen that is well labeled?

What are we trying to achieve? Through communication we can: Test level of knowledge Gauge attitude and morale Seek guidance on priority areas   

Exercise - 20 mins 1.Divide into pairs. Using the handout as a guide, act out a typical discussion between a District TB Coordinator and a Lab Manager. The person doing the monitoring should take notes. After a 5 minute discussion, discuss findings. 2.Now start again, this time with your NTP Supervisor. Again, discuss your findings.

Analyzing Quality of Diagnosis - Advanced  Positivity rate amongst TB suspects  Positivity rate amongst follow-up examinations  Proportion of low-positive suspects  Consistency within series of smears from TB suspects

Evaluating a Laboratory Register ACKNOWLEDGEMENT: Mycobacterium Reference Laboratory Infectious Diseases Laboratories South Australia

Introduction  The Laboratory Register provides a wealth of information –should be reviewed regularly –is an internal Quality Control activity –findings are directly relevant to program management  Provides a simple, easy & rapid method of summarising the work conducted in a laboratory

Positivity Rate Among TB Suspects  Calculated by counting all examinations for TB suspects according to their results –numerator: total up all smear positive results –denominator: total up all positives plus negatives –Expressed as a % Positive (and Scanty) Negatives and Positive (and Scanty )

Positivity Rate Among TB Suspects  Interpretation –varies considerably between countries –Expect 5-20% where TB is prevalent  >20% positivity rate delayed patient presentation delayed diagnosis  <5% positivity rate over selection of TB suspects large numbers of false-negative laboratory results

Positivity Rate Among Follow-up Patients  Calculated by counting all examinations for follow-up cases according to their results –numerator: total up all smear-positive results –denominator: total up all positives plus negatives –Expressed as a % Scanty and Positive Negatives and Scanty and Positive

Positivity Rate Among Follow-up Patients  Expected Value: ~10% –Result dependent upon timing of follow-up sputums; if more at 2 months, then higher, but lower if collected late in treatment  A total absence of smear-positives for follow-up is impossible  <5% poor staining or poor microscopy poor quality specimens misconduct

Proportion of “low positives” among AFB-positive TB suspects  Calculated by determining the proportion of smear positive specimens with a Scanty or 1+ result –numerator: total up all scanty + and 1+ results –denominator: total up all positives plus –Expressed as a % Scanty and 1+ Scanty and all Positive

Proportion of “low positives” among AFB-positive TB suspects  Expected Value ~ 40%  Lower result: –good quality staining but poor microscopy (detection requires time and high quality work)  Higher result –poor quality staining (fewer 3+) –poor quality microscope –contamination of CF with environmental mycobacteria

Concluding Comments  Evaluating a Laboratory Register in this way is a very useful tool contributing to Internal Quality Control of the laboratory  May be done monthly or quarterly  May be graphed to display long term trends in performance